Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Living Modified Organism
(LMO)
The image below identifies the LMO through its unique identifier, trade name and a link to this page of the BCH. Click on it to download a larger image on your computer. For help on how to use it go to the LMO quick-links page.
Spring barley lines expressing fish virus antigen (AsGLOp::GP_LTB-S2-1-1)
EN
AsGLOp::GP_LTB-S2-1-1
No
-
Klopina,Organization:Usovsko ()Private sector (business and industry)
78973, CzechiaPhone: +420 583 484 111,Fax:Email: klopina@usovsko.cz,Website: http://usovsko.cz/?p=o-nas,
The spring barley (Hordeum vulgare) was modified for the production of a recombinant vaccine antigen intended for use in oral vaccination of fish. The modified barley expresses a fusion protein comprising the envelope glycoprotein antigen of Spring Viraemia of Carp Sprivivirus cyprinus fused to the heat-labile enterotoxin B subunit (LTB) from Escherichia coli. The glycoprotein antigen represents a major viral surface protein involved in virus attachment and induction of protective immune responses in fish. LTB functions as a mucosal adjuvant and carrier molecule capable of enhancing antigen uptake and immune stimulation at mucosal surfaces. The transgenic plants also express hygromycin B phosphotransferase from Escherichia coli, which was used as a selectable marker during plant transformation. Expression of the recombinant antigen in barley grain was intended to support development of bioencapsulated oral vaccines for fish species belonging to the Cyprinidae family.
The term “Recipient organism” refers to an organism (either already modified or non-modified) that was subjected to genetic modification, whereas “Parental organisms” refers to those that were involved in cross breeding or cell fusion.
-
BCH-ORGA-SCBD-12110-5 Organism Hordeum vulgare (Barley, HORVU)Crops
EN
-
Spring barley lines expressing fish virus antigens (AsGLOp::GP_GFP_S2-1-6)| Usovsko | Production of medical or pharmaceutical compounds (human or animal) (Vaccines), Resistance to antibiotics (Hygromycin)
pBRACT209
EN
- Agrobacterium-mediated DNA transfer
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
|
0.000 kb
|
Some of these genetic elements may be present as fragments or truncated forms. Please see notes below, where applicable.
-
BCH-GENE-SCBD-14991-8 Hygromycin B phosphotransferase gene | Escherichia coli (ECOLX)Protein coding sequence | Resistance to antibiotics (Hygromycin),Selectable marker genes and reporter genes
-
BCH-GENE-SCBD-111062-1 Heat-labile enterotoxin, B subunit gene | Escherichia coli (ECOLX)Protein coding sequence | Production of medical or pharmaceutical compounds (human or animal) (Vaccines)
-
BCH-GENE-SCBD-299479-3 Envelope G glycoprotein | Sprivivirus cyprinus (Spring viremia of carp virus, SVCV, Rhabdovirus carpio, Carp sprivivirus)Protein coding sequence | viral antigen for the development of vaccines
-
BCH-GENE-SCBD-299477-1 AsGLO promoter | Avena sativa (Oat, AVESA)Promoter
-
BCH-GENE-SCBD-100269-8 Nopaline Synthase Gene Terminator | Agrobacterium tumefaciens (Agrobacterium)Terminator
-
BCH-GENE-SCBD-100287-7 CaMV 35S promoter | Cauliflower mosaic virus (CaMV)Promoter
Information on the inserted DNA sequence
The spring barley (Hordeum vulgare L.) cultivar Golden Promise was modified by Agrobacterium tumefaciens-mediated transformation of immature embryos using strain AGL1 carrying the binary vector pBRACT209 (AsGLOp::GP_LTB-S2-1-1). The inserted T-DNA contains an antigen expression cassette encoding the recombinant rGP_LTB fusion protein and a selectable marker cassette encoding hygromycin B phosphotransferase. The transformation construct was designed for preferential accumulation of the recombinant antigen in barley grain endosperm.
(1) Antigen expression cassette
Expression of the recombinant rGP_ LTB coding sequence is controlled by the endosperm-specific AsGLO promoter derived from the globulin 1 gene of oat (Avena sativa), with transcription terminated by the nopaline synthase terminator (NOSt) derived from Agrobacterium tumefaciens. The AsGLO promoter originates from the barley hordein storage-protein regulatory region and exhibits endosperm-preferential activity, resulting in expression predominantly within developing grain tissues. This tissue-specific promoter was selected to promote accumulation of recombinant vaccine antigens within the seed, facilitating antigen bioencapsulation and oral delivery through feed.
The rGP_ LTB coding sequence is a chimeric sequence encoding a recombinant fusion protein comprising a fragment of the Spring Viraemia of Carp Virus (SVCV) envelope glycoprotein (GP) and heat-labile enterotoxin B subunit (LTB) derived from Escherichia coli. The GP fragment corresponds to amino acid residues 243–337 of the SVCV envelope glycoprotein (95 amino acids). The SVCV glycoprotein is a viral envelope protein involved in receptor-mediated attachment and entry into host cells and is immunogenic, capable of eliciting host immune responses. LTB is a non-toxic mucosal adjuvant that binds GM1 ganglioside receptors and is frequently incorporated into recombinant oral vaccine formulations to enhance antigen uptake and stimulation of mucosal immune responses.
The rGP_LTB coding sequence includes additional elements not shown in the genetic construct diagram: The N-terminal signal peptide (ZmCKX1) directs the recombinant protein into the secretory pathway, the C-terminal signal (KDEL) promotes retention and accumulation of the recombinant protein in the endoplasmic reticulum. The recombinant construct additionally contains two 6×His tags for immunodetection and purification, separated by a flexible (GGGGS)₂ linker; and a Myc epitope tag (EQKLISEEDL) for immunodetection (Micúchová et al., 2024). The chimeric coding sequence was optimized for barley codon usage.
2) Selectable marker cassette
Expression of the recombinant rGP_ LTB coding sequence is controlled by the endosperm-specific AsGLO promoter derived from the globulin 1 gene of oat (Avena sativa), with transcription terminated by the nopaline synthase terminator (NOSt) derived from Agrobacterium tumefaciens. The AsGLO promoter originates from the barley hordein storage-protein regulatory region and exhibits endosperm-preferential activity, resulting in expression predominantly within developing grain tissues. This tissue-specific promoter was selected to promote accumulation of recombinant vaccine antigens within the seed, facilitating antigen bioencapsulation and oral delivery through feed.
The rGP_ LTB coding sequence is a chimeric sequence encoding a recombinant fusion protein comprising a fragment of the Spring Viraemia of Carp Virus (SVCV) envelope glycoprotein (GP) and heat-labile enterotoxin B subunit (LTB) derived from Escherichia coli. The GP fragment corresponds to amino acid residues 243–337 of the SVCV envelope glycoprotein (95 amino acids). The SVCV glycoprotein is a viral envelope protein involved in receptor-mediated attachment and entry into host cells and is immunogenic, capable of eliciting host immune responses. LTB is a non-toxic mucosal adjuvant that binds GM1 ganglioside receptors and is frequently incorporated into recombinant oral vaccine formulations to enhance antigen uptake and stimulation of mucosal immune responses.
The rGP_LTB coding sequence includes additional elements not shown in the genetic construct diagram: The N-terminal signal peptide (ZmCKX1) directs the recombinant protein into the secretory pathway, the C-terminal signal (KDEL) promotes retention and accumulation of the recombinant protein in the endoplasmic reticulum. The recombinant construct additionally contains two 6×His tags for immunodetection and purification, separated by a flexible (GGGGS)₂ linker; and a Myc epitope tag (EQKLISEEDL) for immunodetection (Micúchová et al., 2024). The chimeric coding sequence was optimized for barley codon usage.
2) Selectable marker cassette
The T-DNA additionally contains a hygromycin B phosphotransferase (hpt) gene derived from Escherichia coli. The hpt gene encodes an aminoglycoside phosphotransferase enzyme that detoxifies hygromycin B and permits selection of transformed cells during tissue culture and plant regeneration. Expression of the selectable marker is controlled by the Cauliflower mosaic virus 35S promoter (35Sp) and the nopaline synthase terminator (NOSt) derived from Agrobacterium tumefaciens.
Note
- PCR analysis confirmed integration of the recombinant-antigen sequence and the hpt selectable marker in transgenic barley plants. The complete transformation cassette was subsequently monitored by PCR during selection of progeny.
- Expression of the recombinant GP-LTB fusion protein in seeds was confirmed by Western blot analysis.
- Homozygous transgenic lines were recovered through successive generations of selection and breeding.
EN
- Pharmaceutical
- Research
- Vaccine
- Supplementary material.pdf ( Barley, detection, oral vaccine, aquaculture ) [ English ]
The modified barley can be detected by conventional PCR using genomic DNA extracted from plant tissue. Primer sequences and PCR conditions are provided in the supplementary material of Micúchová et al. (2024).
Aquaculture, representing a sustainable source of global fish production, faces a major challenge in the spread of infectious diseases. Vaccination is the most effective preventive measure, with oral application being considered the most practical method. However, its wider use is currently limited by insufficient stimulation of the gut-associated lymphoid tissue. A promising solution is the production of recombinant vaccines through plants, whose cells allow for the targeted storage of antigens in specific organelles, ensuring their bioencapsulation. Furthermore, plant cells contain natural compounds with adjuvant effects that can enhance immune system activation.
The transformation event listed is the transformation event provided by the submitter. Should the line be commercialized and transformation event available, the record will be updated.
The transformation event listed is the transformation event provided by the submitter. Should the line be commercialized and transformation event available, the record will be updated.
| Record type | Field | Record(s) | |
|---|---|---|---|
| Risk Assessment generated by a regulatory process | Living modified organism(s) | 1 | |
| Living Modified Organism | Recipient Organism or Parental Organisms | 1 | |
| Living Modified Organism | Related LMO(s) | 1 | |